Stay updated on Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial page.

Latest updates to the Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page displays a newer revision number (v3.6.6) replacing the previous v3.6.5, signaling that the ClinicalTrials.gov record was refreshed.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedA new page revision tag (v3.6.5) appears, and the related topics block including 'Prostate cancer' and 'MedlinePlus Genetics' along with the prior revision tag ('Revision: v3.6.4') has been removed.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page adds related topics for Prostate cancer and MedlinePlus Genetics. This expands navigation to consumer health resources related to the study.SummaryDifference0.2%

- Check50 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, representing a minor update to the page’s version. No substantive study content is reflected in this change.SummaryDifference0.1%

- Check57 days agoChange DetectedRelated topics metadata has been updated by removing 'Prostate cancer' and 'MedlinePlus Genetics' as related topics, and the related topics header has been removed. This reflects a downsizing of topic tagging around the study without changing the study content.SummaryDifference0.2%

- Check64 days agoChange DetectedThe related topics section now includes Prostate cancer and MedlinePlus Genetics, linking to educational resources.SummaryDifference0.2%

Stay in the know with updates to Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial page.